Case Name: Horizon Medicines LLC v. Apotex Inc., Civ. No. 22-640-CJB, 2022 WL 16739909 (D. Del. Nov. 7, 2022) (Burke, M.J.) Drug Product and Patent(s)-in-Suit: Pennsaid® 2% (diclofenac.
In a victory with far-reaching implications for patent licensing and litigation, Deepro Mukerjee, chair of Katten's global Intellectual Property practice, Lance Soderstrom, co-chair of the firm's Patent Litigation practice.